EWM
NVCR icon

Empirical Wealth Management’s NovoCure NVCR Stock Holding History

Empirical Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198K Sell
13,059
-5,081
-28% -$76.9K ﹤0.01% 1023
2026
Q1 		$198K Buy
+18,140
New +$227K ﹤0.01% 951

Other funds holding NVCR

BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Empirical Wealth Management's NVCR Position: Q2 2026 in Review

Empirical Wealth Management reduced its NovoCure (NVCR) stake by 28% in Q2 2026, selling an estimated $76.9K and leaving 13,059 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Empirical Wealth Management first reported a position in NVCR in Q1 2026 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Empirical Wealth Management held 13,059 shares of NovoCure worth $198K as of Q2 2026.
  • Empirical Wealth Management sold 5,081 NovoCure shares in Q2 2026, an estimated $76.9K.
  • NovoCure made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #1023 holding.
  • Empirical Wealth Management first reported a position in NovoCure in Q1 2026 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.